Derek Mann, Chair of Hepatology at Newcastle University, has made a series of discoveries that help describe mechanisms by which liver disease progresses to cirrhosis. He identified epigenetic processes controlling the fibrosis-promoting activities of liver myofibroblasts and led the discovery of angiotensin and serotonin pathways that become deranged in liver disease and translated this work to a clinical study on Losartan in fatty liver disease. Professor Mann’s leadership is demonstrated by 10 years directorship of the Newcastle Fibrosis Group which is considered world-leading. He was also previously Scientific Director of the Institute of Cellular Medicine and was recently appointed Dean of Research for the Faculty of Medicine at Newcastle.
FellowBack to directory listing
Professor Derek Mann FMedSci
Chair of Hepatology
Faculty of Medical Sciences
The biology of inflammation, fibrosis and cancer in the context of age-related chronic disease.Section committee elected by
Medical and veterinary specialties and paediatrics